By Samuel Wamuttu on July 27, 2017
Adelaide, and Professor David A. Cooper from the Kirby Institute, Australia, author of the LATTE-2 study Dr David Margolis, Canada, France, France and Germany, Germany, injectable antiretroviral therapy (ART), international aids society, new phase 2 trial published in The Lancet, paris, Professor Joe Eron, Professor Mark A. Boyd, Spain, Sydney, two drugs (cabotegravir and rilpivirine), university of adelaide, University of New South Wales, University of North Carolina at Chapel Hill, USA, ViiV Healthcare
Health, Health & Medical, Latest Uganda News
An injectable antiretroviral therapy (ART) consisting of two drugs (cabotegravir and rilpivirine) administered every four or eight weeks may be as effective as a daily oral dose of the drugs in maintaining viral suppression in patients with HIV, according to a new phase 2 trial published in The Lancet. In the study, patients were given […]
